Q2 2024 Holdings
Filed 2024-08-14 | 90 holdings | $746.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $42.5M | 551,592 | 5.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $36.2M | 179,305 | 4.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $35.5M | 111,381 | 4.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $28.7M | 31,654 | 3.8% |
| Cooper COS Inc(COO) | COM | 216648501 | $26.9M | 308,398 | 3.6% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $19.8M | 148,927 | 2.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $19.2M | 446,416 | 2.6% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $18.8M | 694,178 | 2.5% |
| Rxsight Inc(RXST) | COM | 78349D107 | $17.9M | 296,739 | 2.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $17.8M | 156,855 | 2.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $15.9M | 68,167 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $15.9M | 115,170 | 2.1% |
| Elevance Health Inc(ELV) | COM | 036752103 | $15.0M | 27,751 | 2.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $14.0M | 721,373 | 1.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $12.7M | 185,028 | 1.7% |
| Abbott Labs(ABT) | COM | 002824100 | $12.7M | 121,913 | 1.7% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $12.6M | 2,409,599 | 1.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $12.5M | 908,822 | 1.7% |
| Merck & Co Inc(MRK)Put | COM | 58933Y105 | $12.4M | 100,000 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $12.3M | 600,698 | 1.7% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $12.1M | 647,142 | 1.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $11.6M | 37,056 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.3M | 150,191 | 1.5% |
| Humana Inc(HUM) | COM | 444859102 | $11.2M | 30,037 | 1.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $10.8M | 535,063 | 1.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.3M | 574,517 | 1.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $9.9M | 474,679 | 1.3% |
| Qiagen NV(QGEN) | SHS NEW | N72482149 | $9.6M | 234,267 | 1.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $9.4M | 195,567 | 1.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $9.1M | 198,627 | 1.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $8.9M | 852,416 | 1.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.7M | 156,843 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $8.6M | 595,389 | 1.2% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $8.6M | 125,000 | 1.1% |
| Cencora Inc(COR) | COM | 03073E105 | $8.6M | 38,014 | 1.1% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $8.3M | 200,000 | 1.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.2M | 209,290 | 1.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $8.0M | 969,892 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.7M | 161,705 | 1.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.4M | 256,307 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $6.3M | 141,375 | 0.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $6.3M | 415,535 | 0.8% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $6.3M | 76,079 | 0.8% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $6.0M | 277,895 | 0.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $5.8M | 353,942 | 0.8% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $5.7M | 876,268 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $5.5M | 289,841 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.4M | 80,271 | 0.7% |
| Cvrx Inc(CVRX) | COM | 126638105 | $5.4M | 447,620 | 0.7% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $5.4M | 1,148,307 | 0.7% |